TuHURA Biosciences, Inc.

HURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$21,682-$29,317-$9,368-$7,017
Dep. & Amort.$117$177$373$381
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,959$479$218$655
Change in WC$3,287$487$1,562-$55
Other Non-Cash$1,592$20,998-$294-$527
Operating Cash Flow-$14,728-$11,951-$7,508-$6,563
Investing Activities
PP&E Inv.-$58-$79-$36-$3
Net Acquisitions-$5,995-$1,218$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$6,052-$1,297-$36-$3
Financing Activities
Debt Repay.$28,568$2,685-$350$294
Stock Issued$5,000$0$0$5,600
Stock Repurch.$0-$25$0$0
Dividends Paid$0$0$0-$8
Other Fin. Act.-$3,795$25$16,601$1,158
Financing Cash Flow$29,773$2,660$16,251$7,045
Forex Effect$0$0$0$0
Net Chg. in Cash$8,992-$10,587$8,706$478
Supplemental Information
Beg. Cash$3,665$14,253$5,546$5,068
End Cash$12,657$3,665$14,253$5,546
Free Cash Flow-$14,786-$12,030-$7,545-$6,567